ReviewFrontiers in medicine2026
Reactive oxygen species and antioxidant strategies in human sperm cryodamage.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sperm cryopreservation is widely used for male fertility preservation and assisted reproduction technologies; however, the freezing and thawing process can induce irreversible structural and functional damage to human spermatozoa. This review summarizes the main mechanisms through which cryopreservation disrupts redox homeostasis, with particular emphasis on the generation of reactive oxygen species, mitochondrial dysfunction, lipid peroxidation, DNA fragmentation, and the consequent impairment of sperm motility and viability. Human spermatozoa are particularly vulnerable to oxidative damage because they possess limited cytoplasmic antioxidant defenses and a plasma membrane rich in polyunsaturated fatty acids (PFA), which are highly susceptible to peroxidative injury. In addition, the dilution or removal of seminal plasma during cryopreservation further compromise extracellular antioxidant protection. Experimental studies have shown that supplementation of freezing and/or thawing media with enzymatic and non-enzymatic antioxidants, including catalase, glutathione, ascorbic acid, tocopherols, melatonin, resveratrol, quercetin, MitoTEMPO, myo-inositol, elamipretide, brain-derived neurotrophic factor, and various natural extracts, may improve selected post-thaw sperm parameters and reduce biomarkers of oxidative stress. Nevertheless, no antioxidant strategy currently available is capable of completely preventing cryodamage, and the market heterogeneity of existing protocols limits their clinical translation. Further well-designed human studies are therefore required to determine the safety, efficacy, optimal concentration, and clinical utility of antioxidant supplementation in sperm cryopreservation media.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.